Riskpilot← Back to searchSign inGet full accessREDO HOLDING ApS
APSActiveCVR 34706549Korskildelund 4Activities of holding companies · NACE 6421Est. 2012— employees
Revenue 2025
—
EBITDA margin
—
-12% vs 2024
Equity ratio
99.8%
Financial strength
Net profit 2025
DKK 978K
+161% vs 2024
| Revenue | — | — |
| EBITDA | DKK -6K | -12% |
| Net profit | DKK 978K | +161% |
| Total assets | DKK 3,2M | +25% |
| Equity | DKK 3,2M | +25% |
| Employees | — | — |
Legal name
REDO HOLDING ApS
CVR number
34706549
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
20. september 2012
Share capital
DKK 80.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et medlem af bestyrelsen i forening med en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive konsulentvirksomhed, at handle og udvikle kosttilskud og naturlægemidler samt at drive import og eksport forretning.
Address
Korskildelund 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -4 | -14 | -6 | -6 | -6 | -5 | -5 | -5 | -5 | -5 | -6 | -5 | -6 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -4 | -14 | -6 | -6 | -6 | -5 | -5 | -5 | -5 | -5 | -6 | -5 | -6 |
| Net financials | 883 | 720 | 388 | 208 | 843 | 634 | 251 | 284 | 1.028 | -112 | 156 | 380 | 984 |
| Profit before tax | 879 | 707 | 382 | 203 | 837 | 629 | 246 | 279 | 1.023 | -117 | 150 | 375 | 978 |
| Tax | -6 | 6 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | 885 | 700 | 382 | 203 | 837 | 629 | 246 | 279 | 1.023 | -117 | 150 | 375 | 978 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3.006 | 3.504 | 3.065 | 3.302 | 2.609 | 2.722 | 2.458 | 2.360 | 3.133 | 2.016 | 2.167 | 2.542 | 3.180 |
| Equity | 965 | 1.666 | 1.048 | 1.250 | 2.087 | 2.717 | 2.163 | 2.355 | 3.128 | 2.011 | 2.161 | 2.536 | 3.175 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.040 | 1.839 | 2.017 | 2.051 | 522 | 5 | 295 | 5 | 5 | 5 | 6 | 6 | 6 |
| Total debt | 2.040 | 1.839 | 2.017 | 2.051 | 522 | 5 | 295 | 5 | 5 | 5 | 6 | 6 | 6 |
EBITDA margin
-562500.0%
This company
15.8%
Market median
-3560227% vs market
20132025
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20132025
Return on equity
30.8%
This company
18.4%
Market median
+67% vs market
20132025
Net profit margin
97814700.0%
This company
8.1%
Market median
+1207588789% vs market
20132025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20132025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20132025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2012-09-20 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RD Management | Management | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2012 | — | — | |
| Board of Directors | 2012 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PHARMAVIE A/S | Company | 66.7% | 66.7% | 2018 |
DOMINIC HOLDING ApS | Company | 25.0% | 25.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MAW HOLDING ApS
REDO HOLDING ApS Board members of REDO HOLDING ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rene Dominic | Management | 0 companies |
| Carsten Wærn | Chairman | 0 companies |
| Christel Arpalice Piron | Board of Directors | 0 companies |